Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical herbal cream versus mometasone 0.1% for eczema
IRCT20181026041466N5Phase 2Completed
- Sponsor
- Rayka Raya Teb
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mometasone in atopic dermatitis (AD) (2 arms), sponsored by Rayka Raya Teb. Primary endpoints: Eczema symptom management efficacy and Participant consequences. Started Oct 2020; status: completed.
02
Drugs
mometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on IRCT20181026041466N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181026041466N5.